Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.133M Est
Rapid Micro Biosystems (NASDAQ: RPID ) affirms FY2026 sales outlook from $37.000 million-$41.000 million to $37.000 million-$41.000 million vs $39.133 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.